Advent Life Sciences, a transatlantic venture firm focused on life science companies, has closed a pair of new funds tot
Sorry, you need to subscribe to read this article.
If you would like to access this article you must become a Premium Subscriber.
Premium subscribers receive complete access to our daily breaking news, premium stories, weekly Fundraising & IR Review, Knowledge Bank and LP profiles – all which are accessible via our mobile platform.
Subscribe below or contact customerservice@altassets.net
